줄기세포 어세이 시장 : 제품, 어세이, 용도, 지역별(2024-2031년)

Stem Cell Assay Market Valuation - 2024-2031

The growing need for regenerative therapies and personalized medicine is one factor propelling the stem cell assay market. According to the analyst from Verified Market Research, the stem cell assay market is estimated to reach a valuation of USD 7.81 Billion over the forecast period, surpassing around USD 1.93 Billion valued in 2023.

The growing use of stem cell research in toxicology and drug discovery is another factor propelling the market for stem cell assays. It enables the market to grow at a CAGR of 19.07% from 2024 to 2031.

Stem Cell Assay Market: Definition/Overview

A stem cell assay is a laboratory technique for assessing the properties and behavior of stem cells. It entails testing stem cells in controlled conditions to determine their ability to self-renew, differentiate into diverse cell types, and proliferate. Stem cell assays play an important role in biomedical research and regenerative medicine, with applications spanning from drug discovery and development to toxicological screening and disease modelling.

Furthermore, stem cell assays aid in drug development by determining the impact of prospective therapeutic drugs on stem cell differentiation and function. Also, these assays are utilized to research developmental processes, screen for pharmacological toxicities, and investigate disease causes such as cancer and neurological illnesses.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What are the Aspects Influencing the Growth of the Stem Cell Assay Market?

Continuous advancements in stem cell research, as well as the development of breakthrough methods for stem cell isolation, culturing, and differentiation, are key drivers. These technical advancements increase the efficiency and effectiveness of stem cell assays, making them more appealing for a variety of applications such as drug development, regenerative medicine, and fundamental research. Innovations such as 3D cell culture techniques, high-throughput screening methodologies, and advances in imaging and analytical tools all help to drive market expansion.

The growing interest in regenerative medicine, as well as the potential of stem cells to treat a variety of ailments such as cardiovascular disease, neurological disorders, and diabetes, is driving demand for stem cell assays. Governments, business companies, and academic institutions are rapidly investing in stem cell research to investigate therapeutic applications, creating a demand for tests used to assess the efficiency and safety of stem cell-based therapies.

Furthermore, the increasing global prevalence of chronic diseases and genetic disorders needs the development of new medicines and therapies. Stem cells represent a possible option for generating such treatments, increasing the demand for stem cell assays in disease modelling, drug development, and personalized medicine. The need for stem cell assays is increasing as academics and pharmaceutical companies work to better understand disease causes and test new treatments.

Will Technical Issues of Stem Cell Assay Impact the Growth of Market?

Despite advances in stem cell research, significant technical and scientific challenges remain, such as efficiently differentiating stem cells into desired cell types, maintaining the stability and purity of stem cell cultures, and ensuring assay reproducibility across multiple laboratories. These challenges have an impact on the reliability and effectiveness of stem cell assays, making it difficult to standardize techniques and generate consistent results, hence limiting market expansion.

Creating and running stem cell assays necessitates significant expenditure on specialised equipment, reagents, and expert personnel. The high costs of these assays represent a hurdle for academic institutions and small-to-medium businesses with limited resources. Furthermore, the long-term nature of stem cell research, as well as uncertainties about the commercial feasibility of stem cell-based medicines, represent major investment risks. These financial obstacles stymie the growth of the stem cell assay business, limiting its expansion.

Category-wise Acumens

What dynamics Contribute to the Dominance of Reagents and Kits Products?

According to VMR analyst, the reagents and kits segment is estimated to dominate the stem cell assay market during the forecast period. Reagents and kits are consumables used extensively in stem cell tests such as cell proliferation, differentiation, viability, and toxicity. Reagents and kits are in high demand due to their importance in daily laboratory operations and their recurrent nature. This need is being driven by continuous research and development efforts in both academic and commercial contexts, where stem cell assays are critical for drug discovery, therapeutic development, and basic research.

Reagents and kits are designed to meet a wide range of needs, from basic research to specific therapeutic areas. This versatility is strengthened by the ability to tailor kits to specific types of stem cells or tests. Such customization and application flexibility ensure that reagents and kits continue to be in high demand across a wide range of research areas and medicinal development projects, contributing to their market domination.

Furthermore, compared to instruments, which require significant initial capital investment and maintenance expenditures, reagents and kits are less expensive and more accessible to a larger range of customers, including small research labs and entrepreneurs. This decreased cost barrier promotes widespread adoption and continuing purchasing of reagents and kits, resulting in a bigger market share.

How do the Cytotoxicity Assays Influence the Growth Trajectory of the Market?

The viability or cytotoxicity assays segment is estimated to hold the largest share of the stem cell assay market during the forecast period. Viability or cytotoxicity assays are critical for determining the effects of medicines on cell health and survival, making them indispensable during the early stages of drug discovery and development. These tests assist evaluate the therapeutic index of drug candidates by analyzing their toxic effects on cells, making them critical in discovering possible treatments with the fewest cytotoxic effects.

Additionally, the expanding pharmaceutical and biotechnology companies' investment in new drug development fueling demand for these assays.

Furthermore, viability or cytotoxicity assays are versatile and can be used in a variety of research domains, including toxicology, cancer, and regenerative medicine. They are employed not just in stem cell research, but also in experiments with primary cells, cancer cells, and other cell lines. This broad applicability across several scientific and clinical sectors leads to their large market share.

Country/Region-wise Acumens

What are the Key Drivers Influencing the North American Stem Cell Assay Market?

North America is estimated to dominate the stem cell assay market during the forecast period. North America, particularly the United States, has a strong research and development infrastructure, with world-class universities, research institutions, and biotechnology and pharmaceutical corporations. This environment encourages innovation and enables ground-breaking research in stem cell technology and applications.

The presence of excellent research facilities and a highly skilled workforce facilitates the development, validation, and commercialization of stem cell assays, contributing considerably to the region's market leadership.

Furthermore, compared to other regions, North America, particularly the United States, offers a more favourable regulatory framework for stem cell research and therapeutic development. Regulatory authorities, such as the United States Food and Drug Administration (FDA), have created criteria and routes for the research and approval of stem cell-based medicines. This regulatory environment promotes innovation while maintaining safety and efficacy, making the region appealing to enterprises and researchers involved in the stem cell assay market.

What Factors Contribute to Surging Demand for Stem Cell Assays in the Asia Pacific?

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Many Asian Pacific countries have established major programs and financing schemes to encourage life science research and development, such as stem cell research and regenerative medicine. Governments in Japan, South Korea, China, and Australia are aggressively pushing stem cell research by providing direct money, establishing research centres, and forming collaborations with the commercial sector. These efforts aim to establish these countries as worldwide leaders in biotechnology and healthcare innovation, ultimately boosting the growth of the stem cell assay market.

Furthermore, Asia Pacific is experiencing an increase in the prevalence of chronic diseases such as diabetes, cardiovascular disease, and neurological disorders, owing to an ageing population. This demographic transition raises the demand for novel cures and medical treatments, particularly those based on stem cell research. Stem cell assays are crucial in the development of these therapies because they facilitate drug discovery, toxicity testing, and disease mechanism comprehension, hence promoting regional market growth.

Competitive Landscape

The competitive landscape of the stem cell assay market is defined by a dynamic interaction of many elements, such as technological breakthroughs, R&D initiatives, regulatory frameworks, and strategic alliances. Furthermore, the presence of severe regulatory requirements for stem cell research and therapeutic development emphasizes the necessity of compliance and quality assurance, which increases market rivalry.

Some of the prominent players operating in the stem cell assay market include:

Thermo Fisher Scientific

Merck KGaA

Danaher

Becton, Dickinson and Company

Bio-Rad Laboratories

PerkinElmer

Agilent Technologies

Promega Corporation

Cell Biolabs

Miltenyi Biotec

STEMCELL Technologies

Bio-Techne Corporation

FUJIFILM Holdings Corporation

Sartorius Stedim Biotech

GE Healthcare

Roche Diagnostics

Latest Developments:

In February 2024, Thermo Fisher, a prominent market player, introduced an innovative serum-free stem cell culture medium that claims to promote stem cell multiplication and differentiation. This could be a huge advancement for companies developing stem cell medicines.

In February 2024, Danaher, another significant competitor, purchased a company that specializes in cell analysis technology. Danaher's position in the stem cell assay industry could be strengthened by this acquisition, which will provide improved stem cell characterization tools.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STEM CELL ASSAY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL STEM CELL ASSAY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL STEM CELL ASSAY MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Reagents and Kits
• 5.3 Instruments

6 GLOBAL STEM CELL ASSAY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Regenerative Medicine and Therapy
• 6.3 Clinical Research
• 6.4 Drug Discovery and Development

7 GLOBAL STEM CELL ASSAY MARKET, BY ASSAY

• 7.1 Overview
• 7.2 Cell Identification Assays
• 7.3 Viability or Cytotoxicity Assays
• 7.4 Apoptosis Assays
• 7.5 Isolation & Purification Assays
• 7.6 Others

8 GLOBAL STEM CELL ASSAY MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL STEM CELL ASSAY MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Thermo Fisher Scientific
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Perkinelmer
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Stemcell Technologies
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Merck
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Bio-Rad Laboratories
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Agilent Technologies
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments

11 Appendix

• 11.1 Related Research